List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Conjugate Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Conjugate Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Market by End Users
1.3.1 Global Conjugate Vaccine Market Size Growth Rate by End Users, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Conjugate Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Conjugate Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Conjugate Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Conjugate Vaccine Sales by Region
2.4.1 Global Conjugate Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Conjugate Vaccine by Region (2023-2028)
2.5 Global Conjugate Vaccine Revenue by Region
2.5.1 Global Conjugate Vaccine Revenue by Region (2017-2022)
2.5.2 Global Conjugate Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Conjugate Vaccine Sales by Manufacturers
3.1.1 Global Top Conjugate Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Conjugate Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Conjugate Vaccine in 2021
3.2 Global Conjugate Vaccine Revenue by Manufacturers
3.2.1 Global Conjugate Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Conjugate Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Conjugate Vaccine Revenue in 2021
3.3 Global Conjugate Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Conjugate Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Conjugate Vaccine Sales by Type
4.1.1 Global Conjugate Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Conjugate Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Conjugate Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Conjugate Vaccine Revenue by Type
4.2.1 Global Conjugate Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Conjugate Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Conjugate Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Conjugate Vaccine Price by Type
4.3.1 Global Conjugate Vaccine Price by Type (2017-2022)
4.3.2 Global Conjugate Vaccine Price Forecast by Type (2023-2028)
5 Market Size by End Users
5.1 Global Conjugate Vaccine Sales by End Users
5.1.1 Global Conjugate Vaccine Historical Sales by End Users (2017-2022)
5.1.2 Global Conjugate Vaccine Forecasted Sales by End Users (2023-2028)
5.1.3 Global Conjugate Vaccine Sales Market Share by End Users (2017-2028)
5.2 Global Conjugate Vaccine Revenue by End Users
5.2.1 Global Conjugate Vaccine Historical Revenue by End Users (2017-2022)
5.2.2 Global Conjugate Vaccine Forecasted Revenue by End Users (2023-2028)
5.2.3 Global Conjugate Vaccine Revenue Market Share by End Users (2017-2028)
5.3 Global Conjugate Vaccine Price by End Users
5.3.1 Global Conjugate Vaccine Price by End Users (2017-2022)
5.3.2 Global Conjugate Vaccine Price Forecast by End Users (2023-2028)
6 North America
6.1 North America Conjugate Vaccine Market Size by Type
6.1.1 North America Conjugate Vaccine Sales by Type (2017-2028)
6.1.2 North America Conjugate Vaccine Revenue by Type (2017-2028)
6.2 North America Conjugate Vaccine Market Size by End Users
6.2.1 North America Conjugate Vaccine Sales by End Users (2017-2028)
6.2.2 North America Conjugate Vaccine Revenue by End Users (2017-2028)
6.3 North America Conjugate Vaccine Market Size by Country
6.3.1 North America Conjugate Vaccine Sales by Country (2017-2028)
6.3.2 North America Conjugate Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Conjugate Vaccine Market Size by Type
7.1.1 Europe Conjugate Vaccine Sales by Type (2017-2028)
7.1.2 Europe Conjugate Vaccine Revenue by Type (2017-2028)
7.2 Europe Conjugate Vaccine Market Size by End Users
7.2.1 Europe Conjugate Vaccine Sales by End Users (2017-2028)
7.2.2 Europe Conjugate Vaccine Revenue by End Users (2017-2028)
7.3 Europe Conjugate Vaccine Market Size by Country
7.3.1 Europe Conjugate Vaccine Sales by Country (2017-2028)
7.3.2 Europe Conjugate Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Conjugate Vaccine Market Size by Type
8.1.1 Asia Pacific Conjugate Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Conjugate Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Conjugate Vaccine Market Size by End Users
8.2.1 Asia Pacific Conjugate Vaccine Sales by End Users (2017-2028)
8.2.2 Asia Pacific Conjugate Vaccine Revenue by End Users (2017-2028)
8.3 Asia Pacific Conjugate Vaccine Market Size by Region
8.3.1 Asia Pacific Conjugate Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Conjugate Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Conjugate Vaccine Market Size by Type
9.1.1 Latin America Conjugate Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Conjugate Vaccine Revenue by Type (2017-2028)
9.2 Latin America Conjugate Vaccine Market Size by End Users
9.2.1 Latin America Conjugate Vaccine Sales by End Users (2017-2028)
9.2.2 Latin America Conjugate Vaccine Revenue by End Users (2017-2028)
9.3 Latin America Conjugate Vaccine Market Size by Country
9.3.1 Latin America Conjugate Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Conjugate Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Conjugate Vaccine Market Size by Type
10.1.1 Middle East and Africa Conjugate Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Conjugate Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Conjugate Vaccine Market Size by End Users
10.2.1 Middle East and Africa Conjugate Vaccine Sales by End Users (2017-2028)
10.2.2 Middle East and Africa Conjugate Vaccine Revenue by End Users (2017-2028)
10.3 Middle East and Africa Conjugate Vaccine Market Size by Country
10.3.1 Middle East and Africa Conjugate Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Conjugate Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Corporation Information
11.5.2 Walvax Biotechnology Overview
11.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Walvax Biotechnology Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Walvax Biotechnology Recent Developments
11.6 Royal (Wuxi) Bio-Pharmaceutical
11.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
11.6.2 Royal (Wuxi) Bio-Pharmaceutical Overview
11.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
11.7 Bharat Biotech
11.7.1 Bharat Biotech Corporation Information
11.7.2 Bharat Biotech Overview
11.7.3 Bharat Biotech Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bharat Biotech Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bharat Biotech Recent Developments
11.8 Zhifei Biologic
11.8.1 Zhifei Biologic Corporation Information
11.8.2 Zhifei Biologic Overview
11.8.3 Zhifei Biologic Conjugate Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhifei Biologic Conjugate Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhifei Biologic Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Conjugate Vaccine Industry Chain Analysis
12.2 Conjugate Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Conjugate Vaccine Production Mode & Process
12.4 Conjugate Vaccine Sales and Marketing
12.4.1 Conjugate Vaccine Sales Channels
12.4.2 Conjugate Vaccine Distributors
12.5 Conjugate Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Conjugate Vaccine Industry Trends
13.2 Conjugate Vaccine Market Drivers
13.3 Conjugate Vaccine Market Challenges
13.4 Conjugate Vaccine Market Restraints
14 Key Findings in The Global Conjugate Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
